Integral Ad Science (NASDAQ:IAS) Given New $17.00 Price Target at Truist Financial

Integral Ad Science (NASDAQ:IAS) had its price objective hoisted by Truist Financial from $16.00 to $17.00 in a research note released on Monday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

Several other research firms have also recently issued reports on IAS. Barclays reissued an “equal weight” rating on shares of Integral Ad Science in a research report on Friday. Craig Hallum cut their target price on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Scotiabank initiated coverage on Integral Ad Science in a report on Friday. They set a “sector perform” rating and a $12.00 price objective for the company. Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a research note on Friday. Finally, Oppenheimer reaffirmed an “outperform” rating on shares of Integral Ad Science in a research report on Friday. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $15.06.

Integral Ad Science Stock Up 1.9 %

Shares of NASDAQ IAS opened at $10.72 on Monday. Integral Ad Science has a 12-month low of $7.98 and a 12-month high of $13.62. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. The firm’s 50-day moving average price is $10.34 and its 200-day moving average price is $10.82. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of 53.60, a P/E/G ratio of 1.06 and a beta of 1.46.

Integral Ad Science (NASDAQ:IAS) last announced its earnings results on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $153.00 million during the quarter, compared to analysts’ expectations of $148.83 million. During the same period in the prior year, the company posted $0.06 EPS. The company’s revenue was up 13.9% compared to the same quarter last year. On average, equities research analysts anticipate that Integral Ad Science will post 0.26 EPS for the current fiscal year.

Insider Activity

In related news, CEO Lisa Utzschneider sold 12,448 shares of the company’s stock in a transaction dated Tuesday, February 4th. The shares were sold at an average price of $10.61, for a total transaction of $132,073.28. Following the completion of the transaction, the chief executive officer now owns 278,650 shares in the company, valued at $2,956,476.50. This represents a 4.28 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 19,109 shares of company stock worth $197,696 in the last ninety days. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Integral Ad Science

Several hedge funds and other institutional investors have recently made changes to their positions in IAS. US Bancorp DE raised its holdings in Integral Ad Science by 540.9% in the 3rd quarter. US Bancorp DE now owns 35,776 shares of the company’s stock valued at $387,000 after acquiring an additional 30,194 shares during the last quarter. Stoneridge Investment Partners LLC acquired a new position in Integral Ad Science during the third quarter worth $125,000. TimesSquare Capital Management LLC boosted its holdings in Integral Ad Science by 0.6% during the 3rd quarter. TimesSquare Capital Management LLC now owns 2,772,440 shares of the company’s stock valued at $29,970,000 after acquiring an additional 17,166 shares during the period. Oppenheimer & Co. Inc. acquired a new position in shares of Integral Ad Science in the third quarter valued at approximately $281,000. Finally, Quest Partners LLC grew its stake in shares of Integral Ad Science by 101,255.9% in the third quarter. Quest Partners LLC now owns 34,461 shares of the company’s stock worth $373,000 after acquiring an additional 34,427 shares in the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.